CINACALCET Side Effects

7019228-X | Bone Giant Cell Tumour
on Sep 20, 2010 Male patient from NETHERLANDS , 43 years of age, was diagnosed with hyperparathyroidism secondary and was treated with Cinacalcet (View Usage). Patient experienced the following unwanted or unexpected effects: bone giant cell tumour. Cinacalcet dosage: . During the same period patient was treated with CALCIDOL (View Calcidol Review and Calcidol Label ), SEVELAMER (View Sevelamer Review and Sevelamer Label ). Patient was hospitalized.

7003594-5 | Blood Alkaline Phosphatase Increased, Bone Formation Test Abnormal, Osteitis
Patient was taking Cinacalcet (View Usage). Patient had the following side effects: blood alkaline phosphatase increased, bone formation test abnormal, osteitis on Sep 13, 2010 from JAPAN Additional patient health information: Female patient , 59 years of age, was diagnosed with hyperparathyroidism secondary and. Cinacalcet dosage: . During the same period patient was treated with VITAMIN D (View Vitamin D Review and Vitamin D Label ).

6733855-6 | Intestinal Perforation
Adverse event was reported on May 12, 2010 by a Male patient taking Cinacalcet (View Usage) (Dosage: ) was diagnosed with hyperparathyroidism secondary and. Location: JAPAN , 73 years of age, After Cinacalcet was administered, patient had the following side effects: intestinal perforation. During the same period patient was treated with RENAGEL (View Renagel Review and Renagel Label ). Patient was hospitalized.

6722706-1 | Blood Parathyroid Hormone Abnormal, Hyperviscosity Syndrome, Hypocalcaemia, Multiple Myeloma, Neuropathy Peripheral, Sepsis
on May 04, 2010 Female patient from UNITED STATES , 59 years of age, was diagnosed with hyperparathyroidism primary and was treated with Cinacalcet (View Usage). Patient experienced the following unwanted or unexpected effects: blood parathyroid hormone abnormal, hyperviscosity syndrome, hypocalcaemia, multiple myeloma (What is multiple myeloma?), neuropathy peripheral, sepsis (What is sepsis?). Cinacalcet dosage: . During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), VELCADE (View Velcade Review and Velcade Label ). Patient was hospitalized.


6287438-5 | Blood Parathyroid Hormone Increased, Cardiac Failure, Haemodialysis, Hypocalcaemia, Hypophosphataemia, Orthopnoea, Platelet Count Decreased, Therapeutic Response Decreased
on Jul 22, 2009 Male patient from SPAIN , weighting 119.0 lb, was diagnosed with hyperparathyroidism secondary and was treated with Cinacalcet (View Usage). Patient had the following side effects: blood parathyroid hormone increased, cardiac failure, haemodialysis, hypocalcaemia, hypophosphataemia, orthopnoea, platelet count decreased, therapeutic response decreased. Cinacalcet dosage: . During the same period patient was treated with PARICALCITOL (View Paricalcitol Review and Paricalcitol Label ), SEVELAMER (View Sevelamer Review and Sevelamer Label ), ACFOL (View Acfol Review and Acfol Label ), NEORECORMON (View Neorecormon Review and Neorecormon Label ), NOCTAMID (View Noctamid Review and Noctamid Label ).

6200608-7 | Cardiac Failure, Orthopnoea, Therapeutic Response Decreased, Treatment Noncompliance
Patient was taking Cinacalcet (View Usage). After Cinacalcet was administered, patient had the following side effects: cardiac failure, orthopnoea, therapeutic response decreased, treatment noncompliance on May 14, 2009 from SPAIN Additional patient health information: Male patient , weighting 119.0 lb, was diagnosed with hyperparathyroidism secondary and. Cinacalcet dosage: . During the same period patient was treated with PARICALCITOL (View Paricalcitol Review and Paricalcitol Label ), SEVELAMER (View Sevelamer Review and Sevelamer Label ), ACFOL (View Acfol Review and Acfol Label ), NEORECORMON (View Neorecormon Review and Neorecormon Label ), NOCTAMID (View Noctamid Review and Noctamid Label ).

6141541-9 | Electrocardiogram Qt Prolonged, Hypocalcaemia, Ventricular Arrhythmia
Adverse event was reported on Apr 01, 2009 by a Male patient taking Cinacalcet (View Usage) (Dosage: 60mg Daily Po 90mg Daily Po Approx. 2 Months) . Location: UNITED STATES , 44 years of age, weighting 180.0 lb, Patient experienced the following unwanted or unexpected effects: electrocardiogram qt prolonged, hypocalcaemia, ventricular arrhythmia. Patient was hospitalized.

5754396-9 | Abdominal Pain Upper, Arthralgia, Hypoglycaemia, Nausea, Pancreatitis Chronic
on May 19, 2008 Male patient from UNITED STATES , weighting 110.0 lb, was diagnosed with hyperparathyroidism secondary and was treated with Cinacalcet (View Usage). Patient had the following side effects: abdominal pain upper, arthralgia, hypoglycaemia, nausea (What is nausea?), pancreatitis chronic. Cinacalcet dosage: . During the same period patient was treated with NEURONTIN (View Neurontin Review and Neurontin Label ), LANTUS (View Lantus Review and Lantus Label ), COUMADIN (View Coumadin Review and Coumadin Label ), ATIVAN (View Ativan Review and Ativan Label ), CALCIUM ACETATE (View Calcium Acetate Review and Calcium Acetate Label ). Patient was hospitalized.

5743287-5 | Abdominal Pain Upper, Arthralgia, Hypoglycaemia, Nausea, Pancreatitis Chronic
on May 08, 2008 Male patient from UNITED STATES , weighting 110.0 lb, was diagnosed with hyperparathyroidism secondary and was treated with Cinacalcet (View Usage). After Cinacalcet was administered, patient had the following side effects: abdominal pain upper, arthralgia, hypoglycaemia, nausea (What is nausea?), pancreatitis chronic. Cinacalcet dosage: . During the same period patient was treated with NEURONTIN (View Neurontin Review and Neurontin Label ), LANTUS (View Lantus Review and Lantus Label ), COUMADIN (View Coumadin Review and Coumadin Label ), ATIVAN (View Ativan Review and Ativan Label ). Patient was hospitalized.

5657888-6 | Electrocardiogram St Segment Depression, Hypersensitivity
Patient was taking Cinacalcet (View Usage). Patient experienced the following unwanted or unexpected effects: electrocardiogram st segment depression, hypersensitivity on Feb 25, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 131.2 lb, was diagnosed with hyperparathyroidism secondary and. Cinacalcet dosage: . During the same period patient was treated with PHENERGAN HCL (View Phenergan Hcl Review and Phenergan Hcl Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), NEXIUM (View Nexium Review and Nexium Label ), LIPITOR (View Lipitor Review and Lipitor Label ), QUININE SULFATE (View Quinine Sulfate Review and Quinine Sulfate Label ). Patient was hospitalized.

5607659-1 | Gastritis, Mallory-weiss Syndrome, Upper Gastrointestinal Haemorrhage
Adverse event was reported on Jan 28, 2008 by a Female patient taking Cinacalcet (View Usage) (Dosage: 90 Mg Daily Po) was diagnosed with hyperparathyroidism secondary and. Location: UNITED STATES , weighting 211.6 lb, Patient had the following side effects: gastritis, mallory-weiss syndrome, upper gastrointestinal haemorrhage. Patient was hospitalized.

5418061-X | Convulsion, Hypocalcaemia, Joint Injury
on Aug 06, 2007 Female patient from , 53 years of age, weighting 249.1 lb, was diagnosed with hyperparathyroidism secondary and was treated with Cinacalcet (View Usage). After Cinacalcet was administered, patient had the following side effects: convulsion, hypocalcaemia, joint injury. Cinacalcet dosage: . During the same period patient was treated with ALFACALCIDOL (View Alfacalcidol Review and Alfacalcidol Label ), AQUEOUS CREAM (View Aqueous Cream Review and Aqueous Cream Label ), BECLOMETHASONE DIPROPIONATE (View Beclomethasone Dipropionate Review and Beclomethasone Dipropionate Label ), CALCICHEW (View Calcichew Review and Calcichew Label ), CODEINE PHOSPHATE AND ACETAMINOPHEN (View Codeine Phosphate And Acetaminophen Review and Codeine Phosphate And Acetaminophen Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), PAROXETINE (View Paroxetine Review and Paroxetine Label ).

5368639-7 | Rash Maculo-papular
on Jun 13, 2007 Male patient from UNITED KINGDOM , 54 years of age, was treated with Cinacalcet (View Usage). Patient experienced the following unwanted or unexpected effects: rash maculo-papular. Cinacalcet dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), DEXAMETHASONE 0.5MG TAB (View Dexamethasone 0.5mg Tab Review and Dexamethasone 0.5mg Tab Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), PHENYTOIN (View Phenytoin Review and Phenytoin Label ).

5289347-7 | C-reactive Protein Increased, Cytomegalovirus Infection, Diarrhoea, Febrile Bone Marrow Aplasia, Granulocytes Maturation Arrest, Haemoglobin Decreased, Kidney Transplant Rejection, Pancytopenia, Platelet Count Decreased
Patient was taking Cinacalcet (View Usage). Patient had the following side effects: c-reactive protein increased, cytomegalovirus infection (What is cytomegalovirus infection?), diarrhoea, febrile bone marrow aplasia, granulocytes maturation arrest, haemoglobin decreased, kidney transplant rejection, pancytopenia, platelet count decreased on Mar 26, 2007 from FRANCE Additional patient health information: Female patient , 62 years of age, weighting 125.7 lb, was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?), prophylaxis against transplant rejection and. Cinacalcet dosage: . During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ), ROVALCYTE (450 Mg, Bid) (View Rovalcyte Review and Rovalcyte Label ), NEORAL (View Neoral Review and Neoral Label ), MYFORTIC (Unk, Unk) (View Myfortic Review and Myfortic Label ), PROGRAF (2 Mg, Bid) (View Prograf Review and Prograf Label ). Patient was hospitalized.

5255217-3 | Nephrotic Syndrome, Proteinuria
Adverse event was reported on Feb 22, 2007 by a Female patient taking Cinacalcet (View Usage) (Dosage: ) was diagnosed with pre-existing disease and. Location: UNITED KINGDOM , 52 years of age, weighting 262.4 lb, After Cinacalcet was administered, patient had the following side effects: nephrotic syndrome, proteinuria. During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), AUGMENTIN (View Augmentin Review and Augmentin Label ), BECLOMETHASONE DIPROPIONATE (View Beclomethasone Dipropionate Review and Beclomethasone Dipropionate Label ), CHLORPHENIRAMINE MALEATE (View Chlorpheniramine Maleate Review and Chlorpheniramine Maleate Label ), DOXYCYCLINE (View Doxycycline Review and Doxycycline Label ), EZETIMIBE (View Ezetimibe Review and Ezetimibe Label ), FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ).

4953056-1 | Hypotension, Post Procedural Complication, Troponin Increased
on Feb 17, 2006 Female patient from FRANCE , weighting 165.3 lb, was diagnosed with hyperparathyroidism secondary and was treated with Cinacalcet (View Usage). Patient experienced the following unwanted or unexpected effects: hypotension, post procedural complication, troponin increased. Cinacalcet dosage: . During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), LEVOTHYROX (View Levothyrox Review and Levothyrox Label ), MOPRAL (View Mopral Review and Mopral Label ), TAHOR (View Tahor Review and Tahor Label ), ZYLORIC (View Zyloric Review and Zyloric Label ), CLARITIN (View Claritin Review and Claritin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

4929426-4 | Hypotension
on Feb 17, 2006 Female patient from FRANCE , weighting 165.3 lb, was diagnosed with hyperparathyroidism secondary and was treated with Cinacalcet (View Usage). Patient had the following side effects: hypotension. Cinacalcet dosage: . Patient was hospitalized.

4881841-3 | Disease Progression, Hyperparathyroidism Secondary
Patient was taking Cinacalcet (View Usage). After Cinacalcet was administered, patient had the following side effects: disease progression, hyperparathyroidism secondary on Jun 01, 2005 from PORTUGAL Additional patient health information: Male patient , weighting 125.2 lb, was diagnosed with hyperparathyroidism secondary and. Cinacalcet dosage: . During the same period patient was treated with FOLIC ACID (View Folic Acid Review and Folic Acid Label ), DARBEPOETIN ALFA (View Darbepoetin Alfa Review and Darbepoetin Alfa Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), CAPTOPRIL (View Captopril Review and Captopril Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), ROCALTROL (View Rocaltrol Review and Rocaltrol Label ).

4881822-X | Disease Progression, Hyperparathyroidism Secondary
Adverse event was reported on Jun 01, 2005 by a Female patient taking Cinacalcet (View Usage) (Dosage: ) was diagnosed with hyperparathyroidism secondary and. Location: PORTUGAL , weighting 158.7 lb, Patient experienced the following unwanted or unexpected effects: disease progression, hyperparathyroidism secondary. During the same period patient was treated with CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), BECOZYME (View Becozyme Review and Becozyme Label ), DARBEPOETIN ALFA (View Darbepoetin Alfa Review and Darbepoetin Alfa Label ), VENOFER (View Venofer Review and Venofer Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ).

4874556-9 | Hyperparathyroidism Secondary, Pancreatitis
on Jun 06, 2005 Male patient from PORTUGAL , weighting 218.3 lb, was diagnosed with hyperparathyroidism secondary and was treated with Cinacalcet (View Usage). Patient had the following side effects: hyperparathyroidism secondary, pancreatitis. Cinacalcet dosage: . During the same period patient was treated with DARBEPOETIN ALFA (View Darbepoetin Alfa Review and Darbepoetin Alfa Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), BECOZYME (View Becozyme Review and Becozyme Label ), ZANTAC (View Zantac Review and Zantac Label ), WARFARIN (View Warfarin Review and Warfarin Label ), INDOBUFEN (View Indobufen Review and Indobufen Label ), VENOFER (View Venofer Review and Venofer Label ), CALCIUM GLUCONATE (View Calcium Gluconate Review and Calcium Gluconate Label ).

4744719-1 | Arrhythmia, Back Pain, Cardiogenic Shock, Hyperglycaemia, Hyperkalaemia, Hypocalcaemia, Insomnia
on Jul 07, 2005 Female patient from SPAIN , weighting 145.5 lb, was diagnosed with hyperparathyroidism secondary and was treated with Cinacalcet (View Usage). After Cinacalcet was administered, patient had the following side effects: arrhythmia (What is arrhythmia?), back pain (What is back pain?), cardiogenic shock, hyperglycaemia, hyperkalaemia, hypocalcaemia, insomnia. Cinacalcet dosage: . During the same period patient was treated with PARIET (View Pariet Review and Pariet Label ), NPH INSULIN (View Nph Insulin Review and Nph Insulin Label ), PEPSAMAR (View Pepsamar Review and Pepsamar Label ), ACFOL (View Acfol Review and Acfol Label ), ROHIPNOL (View Rohipnol Review and Rohipnol Label ), BACTROBAN (View Bactroban Review and Bactroban Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ). Patient was hospitalized.

4718357-0 | Appendicitis, Arrhythmia, Back Pain, Cardiogenic Shock, Cyanosis, Dialysis, Dyspnoea, Heart Rate Decreased, Hyperglycaemia
Patient was taking Cinacalcet (View Usage). Patient experienced the following unwanted or unexpected effects: appendicitis (What is appendicitis?), arrhythmia (What is arrhythmia?), back pain (What is back pain?), cardiogenic shock, cyanosis, dialysis (What is dialysis?), dyspnoea, heart rate decreased, hyperglycaemia on Jul 07, 2005 from SPAIN Additional patient health information: Female patient , weighting 145.5 lb, was diagnosed with hyperparathyroidism secondary and. Cinacalcet dosage: . During the same period patient was treated with PARIET (View Pariet Review and Pariet Label ), NPH INSULIN (View Nph Insulin Review and Nph Insulin Label ), PEPSAMAR (View Pepsamar Review and Pepsamar Label ), ACFOL (View Acfol Review and Acfol Label ), ROHIPNOL (View Rohipnol Review and Rohipnol Label ), BACTROBAN (View Bactroban Review and Bactroban Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ). Patient was hospitalized.

4696870-2 | Hypocalcaemia, Papilloedema, Visual Acuity Reduced
Adverse event was reported on May 31, 2005 by a Female patient taking Cinacalcet (View Usage) (Dosage: ) was diagnosed with hyperparathyroidism secondary and. Location: , weighting 158.7 lb, Patient had the following side effects: hypocalcaemia, papilloedema, visual acuity reduced. During the same period patient was treated with CALCIJEX (View Calcijex Review and Calcijex Label ), ROCALTROL (View Rocaltrol Review and Rocaltrol Label ), LASIX (View Lasix Review and Lasix Label ), ADALAT (View Adalat Review and Adalat Label ), LESCOL (View Lescol Review and Lescol Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), RENAGEL (View Renagel Review and Renagel Label ), ARANESP (View Aranesp Review and Aranesp Label ).

4694320-3 | Disease Progression, Hyperparathyroidism Secondary, Pancreatitis
on Jun 06, 2005 Male patient from , weighting 218.3 lb, was diagnosed with hyperparathyroidism secondary and was treated with Cinacalcet (View Usage). After Cinacalcet was administered, patient had the following side effects: disease progression, hyperparathyroidism secondary, pancreatitis. Cinacalcet dosage: . During the same period patient was treated with DARBEPOETIN ALFA (View Darbepoetin Alfa Review and Darbepoetin Alfa Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), BECOZYME (View Becozyme Review and Becozyme Label ), ZANTAC (View Zantac Review and Zantac Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), INDOBUFEN (View Indobufen Review and Indobufen Label ), VENOFER (View Venofer Review and Venofer Label ), CALCIUM GLUCONATE (View Calcium Gluconate Review and Calcium Gluconate Label ).

4680873-8 | Erythema, Photosensitivity Reaction, Skin Ulcer
on Jun 01, 2005 Male patient from , 56 years of age, weighting 169.8 lb, was diagnosed with hyperparathyroidism secondary and was treated with Cinacalcet (View Usage). Patient experienced the following unwanted or unexpected effects: erythema, photosensitivity reaction, skin ulcer. Cinacalcet dosage: 30 Mg Po Q Day. During the same period patient was treated with ATENTOLOL (View Atentolol Review and Atentolol Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), LOSARTAN (View Losartan Review and Losartan Label ).